Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects
Open Access
- 1 June 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 12 (6) , 563-571
- https://doi.org/10.1016/s0895-7061(99)00009-6
Abstract
Our objective was to evaluate the safety and antihypertensive efficacy of sampatrilat, a novel dual inhibitor of both angiotensin-converting enzyme (Keywords
This publication has 0 references indexed in Scilit: